Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxia

被引:26
作者
Fogel, Brent L. [1 ]
Lee, Ji Yong [1 ]
Lane, Jessica [1 ]
Wahnich, Amanda [1 ]
Chan, Sandy [1 ]
Huang, Alden [1 ]
Osborn, Greg E. [1 ]
Klein, Eric [1 ]
Mamah, Catherine [1 ]
Perlman, Susan [1 ]
Geschwind, Daniel H. [1 ,2 ,3 ]
Coppola, Giovanni [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA
关键词
cerebellar ataxia; copy number variation; dominant genetic conditions; recessive genetic conditions; spinocerebellar ataxia; HUNTINGTONS-DISEASE; MOTOR FUNCTION; PLACEBO; IMIPRAMINE; SENATAXIN; AMOXAPINE; HELICASE; ARSACS; REWARD;
D O I
10.1002/mds.24064
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Sporadic-onset ataxia is common in a tertiary care setting but a significant percentage remains unidentified despite extensive evaluation. Rare genetic ataxias, reported only in specific populations or families, may contribute to a percentage of sporadic ataxia. Methods: Patients with adult-onset sporadic ataxia, who tested negative for common genetic ataxias (SCA1, SCA2, SCA3, SCA6, SCA7, and/ or Friedreich ataxia), were evaluated using a stratified screening approach for variants in 7 rare ataxia genes. Results: We screened patients for published mutations in SYNE1 (n = 80) and TGM6 (n = 118), copy number variations in LMNB1 (n = 40) and SETX (n = 11), sequence variants in SACS (n = 39) and PDYN (n 5 119), and the pentanucleotide insertion of spinocerebellar ataxia type 31 (n = 101). Overall, we identified 1 patient with a LMNB1 duplication, 1 patient with a PDYN variant, and 1 compound SACS heterozygote, including a novel variant. Conclusions: The rare genetic ataxias examined here do not significantly contribute to sporadic cerebellar ataxia in our tertiary care population. VC 2012 Movement Disorder Society
引用
收藏
页码:442 / 446
页数:5
相关论文
共 43 条
[1]   Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients [J].
Anheim, M. ;
Monga, B. ;
Fleury, M. ;
Charles, P. ;
Barbot, C. ;
Salih, M. ;
Delaunoy, J. P. ;
Fritsch, M. ;
Arning, L. ;
Synofzik, M. ;
Schoels, L. ;
Sequeiros, J. ;
Goizet, C. ;
Marelli, C. ;
Le Ber, I. ;
Koht, J. ;
Gazulla, J. ;
De Bleecker, J. ;
Mukhtar, M. ;
Drouot, N. ;
Ali-Pacha, L. ;
Benhassine, T. ;
Chbicheb, M. ;
M'Zahem, A. ;
Hamri, A. ;
Chabrol, B. ;
Pouget, J. ;
Murphy, R. ;
Watanabe, M. ;
Coutinho, P. ;
Tazir, M. ;
Durr, A. ;
Brice, A. ;
Tranchant, C. ;
Koenig, M. .
BRAIN, 2009, 132 :2688-2698
[2]   Mutations in SACS cause atypical and late-onset forms of ARSACS [J].
Baets, J. ;
Deconinck, T. ;
Smets, K. ;
Goossens, D. ;
Van den Bergh, P. ;
Dahan, K. ;
Schmedding, E. ;
Santens, P. ;
Rasic, V. Milic ;
Van Damme, P. ;
Robberecht, W. ;
De Meirleir, L. ;
Michielsens, B. ;
Del-Favero, J. ;
Jordanova, A. ;
De Jonghe, P. .
NEUROLOGY, 2010, 75 (13) :1181-1188
[3]  
Bakalkin G, 2010, AM J HUM GENET, V87, P593, DOI 10.1016/j.ajhg.2010.10.001
[4]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[5]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[6]   Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2 [J].
Bernard, Veronica ;
Minnerop, Martina ;
Buerk, Katrin ;
Kreuz, Friedmar ;
Gillessen-Kaesbach, Gabriele ;
Zuehlke, Christine .
BMC MEDICAL GENETICS, 2009, 10 :87
[7]   No gender differences in placebo responses of patients with major depressive disorder [J].
Casper, RC ;
Tollefson, GD ;
Nilsson, ME .
BIOLOGICAL PSYCHIATRY, 2001, 49 (02) :158-160
[8]   Placebo mechanisms and reward circuitry:: Clues from Parkinson's disease [J].
de la Fuente-Fernández, R ;
Schulzer, M ;
Stoessl, AJ .
BIOLOGICAL PSYCHIATRY, 2004, 56 (02) :67-71
[9]   The placebo effect in neurological disorders [J].
de la Fuente-Fernández, R ;
Schulzer, M ;
Stoessel, AJ .
LANCET NEUROLOGY, 2002, 1 (02) :85-91
[10]   Expectation and dopamine release:: Mechanism of the placebo effect in Parkinson's disease [J].
de la Fuente-Fernández, R ;
Ruth, TJ ;
Sossi, V ;
Schulzer, M ;
Calne, DB ;
Stoessl, AJ .
SCIENCE, 2001, 293 (5532) :1164-1166